Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metabolic switching refers to the body's ability to alternate between using glucose and fatty acids/ketones as its main energy source. In the fed state—after eating—glucose from carbohydrates is used preferentially for energy. When food intake ceases for an extended period (fasting), liver glycogen stores become depleted after about 12–36 hours. At this point, the body increases lipolysis in adipose tissue, releasing free fatty acids that are converted into ketone bodies by the liver. These ketones then serve as an alternative fuel source for many tissues including the brain[1][2][4]. This switch enhances metabolic flexibility and has been associated with benefits such as improved weight management, reduced inflammation, better insulin sensitivity, cardiovascular health improvements, increased mitochondrial biogenesis via AMPK activation during fasting states—and potentially neuroprotective effects due to increased BDNF production when running on ketones instead of glucose[1][2]. Because “metabolic switching” describes an adaptive response rather than a discrete molecular entity or druggable target—it should not be classified as a canonical therapeutic target such as an enzyme or receptor. > Flipping the metabolic switch from burning sugar to burning fat is considered beneficial for restoring health and losing weight... you’ll likely experience more energy, less hunger and clearer mind.[2] In summary: **Metabolic switching** is *not* itself a molecular target but rather denotes an important physiological adaptation involving multiple pathways—including insulin signaling and AMPK/mTOR regulation—that underlie transitions between carbohydrate-based metabolism and fat/ketone-based metabolism depending on nutritional status[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metabolic switching.